Skip to Content

Talzenna 0.1 mg Capsule, hard

Licence status
Authorised: 05/01/2024
Active substances
TALAZOPARIB TOSYLATE
Dosage Form
Capsule, hard
Licence number
EU/1/19/1377/007
Licence holder
Pfizer Europe MA EEIG

Licence information

ATC code
L01XK04 talazoparib
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
05/01/2024